［1］Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China［J］.J Hepatol, 2009, 50(1):204-210.
［2］Davis J, Higginbotham A, O'Connor T, et al. Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat ［J］. Ann Nutr Metab, 2007, 51 (1):42-52
［3］Gudbrandsen OA, Wergedahl H, Mork S, et al. Dietary soya protein concentrate enriched with isoflavones reduced fatty liver, increased hepatic fatty acid oxidation and decreased the hepatic mRNA level of VLDL receptor in obese Zucker rats［J］. Br J Nutr, 2006, 96 (2):249-257.
［4］李国莉，赵伟明，杨建军.大豆异黄酮降血脂作用的研究［J］.食品科学，2006，27(10):528-532.
［5］Park KG, Min AK, Koh EH, et al. Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways ［J］. Hepatology, 2008, 48 (5):1477-1186.
［6］Michael McClain R, Wolz E, et al. Acute, subchronic and chronic safety studies with genistein in rats ［J］.Food Chem Toxicol, 2006, 44 (1): 56-80.
［7］冷亮，蒋卓勤，纪桂元.大豆异黄酮对非酒精性脂肪肝大鼠肝脏脂代谢的影响［J］.中华预防医学杂志，2011，45(4):335-339.
［8］Ji G, Zhao X, Leng L, et al. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats ［J］.Lipids Health Dis, 2011, 10:23.
［9］Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile ［J］. Am J Clin Nutr, 2005, 81 (2): 397-408.
［10］Ma L, Jiang Z, Li X, et al. Effect of dietaryprotein on serum lipid profile in hypercholesterolemic people ［J］. Wei Sheng Yan Jiu, 2011, 40(5): 601-603.
［11］蒋卓勤，韦江红，梁洁云，等.不同来源膳食蛋白质对大鼠血脂代谢的影响［J］.中华预防医学杂志，2000，34(3): 191.
［12］韦湘林. 高脂血症与脂肪肝的相关性分析［J］.现代中西医结合杂志，2000，9(1): 8-9.
［13］Shang J, Chen LL, Xiao FX, et al. Resveratrol |
